Bilic R, Simic P, Jelic M, Stern-Padovan R, Dodig D, van Meerdervoort H Pompe, Martinovic S, Ivankovic D, Pecina M, Vukicevic S
Department of Orthopedic Surgery, School of Medicine, University of Zagreb, Salata 11, 10000, Zagreb, Croatia.
Int Orthop. 2006 Apr;30(2):128-34. doi: 10.1007/s00264-005-0045-z. Epub 2006 Feb 28.
We randomly assigned 17 patients with scaphoid non-union at the proximal pole to three treatment groups: (1) autologous iliac graft (n=6), (2) autologous iliac graft + osteogenic protein-1 (OP-1; n=6), and (3) allogenic iliac graft + OP-1 (n=5). Radiographic, scintigraphic, and clinical assessments were performed throughout the follow-up period of 24 months. OP-1 improved the performance of both autologous and allogenic bone implants and reduced radiographic healing time to 4 weeks compared with 9 weeks in group 1. Helical CT scans and scintigraphy showed that in OP-1-treated patients sclerotic bone was replaced by well-vascularised bone. The addition of OP-1 to allogenic bone implant equalised the clinical outcome with the autologous graft procedure. Consequently the harvesting of autologous graft can be avoided.
我们将17例舟骨近端极部骨不连患者随机分为三个治疗组:(1)自体髂骨移植组(n = 6),(2)自体髂骨移植+成骨蛋白-1(OP-1)组(n = 6),以及(3)异体髂骨移植+OP-1组(n = 5)。在整个24个月的随访期内进行了影像学、骨闪烁显像和临床评估。与第1组的9周相比,OP-1改善了自体和异体骨植入物的性能,并将影像学愈合时间缩短至4周。螺旋CT扫描和骨闪烁显像显示,在接受OP-1治疗的患者中,硬化骨被血管丰富的骨所替代。在异体骨植入物中添加OP-1使临床结果与自体移植手术相当。因此,可以避免自体移植物的采集。